October 24, 2022
Aktis
![Aktis](https://mpmbioimpact.com/wp-content/uploads/2022/10/Aktis.png)
Aktis Oncology is a biotechnology company pioneering the discovery and development of a new class of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers.
Aktis Oncology is a biotechnology company pioneering the discovery and development of a new class of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers.